{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:39:28Z","timestamp":1789605568606,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["101-2221-E-182-002-MY3"],"award-info":[{"award-number":["101-2221-E-182-002-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["102-2221-E-182-020-MY3"],"award-info":[{"award-number":["102-2221-E-182-020-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.jconrel.2016.05.052","type":"journal-article","created":{"date-parts":[[2016,5,27]],"date-time":"2016-05-27T00:34:01Z","timestamp":1464309241000},"page":"72-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":151,"special_numbering":"C","title":["Non-invasive, neuron-specific gene therapy by focused ultrasound-induced blood-brain barrier opening in Parkinson's disease mouse model"],"prefix":"10.1016","volume":"235","author":[{"given":"Chung-Yin","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Yi","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiung-Mei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang-Rung","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Hung","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiung-Yin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu-Yi","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Chen","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Kuang","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2016.05.052_bb0005","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/GIM.0b013e31815bf97c","article-title":"Genetics of Parkinson disease","volume":"9","author":"Pankratz","year":"2007","journal-title":"Genet. Med."},{"key":"10.1016\/j.jconrel.2016.05.052_bb0010","first-page":"15","article-title":"Nigral and extranigral pathology in Parkinson's disease","volume":"46","author":"Braak","year":"1995","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.jconrel.2016.05.052_bb0015","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/aje\/kwg068","article-title":"Incidence of Parkinson's disease: variation by age, gender, and race\/ethnicity","volume":"157","author":"Van Den Eeden","year":"2003","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.jconrel.2016.05.052_bb0020","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1523\/JNEUROSCI.4423-08.2009","article-title":"Activity of neurochemically heterogeneous dopaminergic neurons in the substantia nigra during spontaneous and driven changes in brain state","volume":"29","author":"Brown","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jconrel.2016.05.052_bb0025","doi-asserted-by":"crossref","first-page":"15133","DOI":"10.1523\/JNEUROSCI.3739-14.2014","article-title":"The effects of aging on substantia nigra dopamine neurons","volume":"34","author":"Costa","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jconrel.2016.05.052_bb0030","doi-asserted-by":"crossref","first-page":"a009431","DOI":"10.1101\/cshperspect.a009431","article-title":"Parkinson's disease: gene therapies","volume":"2","author":"Coune","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"Suppl. 2","key":"10.1016\/j.jconrel.2016.05.052_bb0035","first-page":"S139","article-title":"Premotor Parkinson's disease: clinical features, detection, and prospects for treatment","volume":"64","author":"Siderowf","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jconrel.2016.05.052_bb0040","first-page":"41","article-title":"GDNF as a candidate striatal target-derived neurotrophic factor for the development of substantia nigra dopamine neurons","volume":"70","author":"Burke","year":"2006","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.jconrel.2016.05.052_bb0045","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/380252a0","article-title":"Functional recovery in parkinsonian monkeys treated with GDNF","volume":"380","author":"Gash","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2016.05.052_bb0050","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1126\/science.290.5492.767","article-title":"Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease","volume":"290","author":"Kordower","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2016.05.052_bb0055","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0165-0173(01)00098-4","article-title":"Sustained delivery of GDNF: towards a treatment for Parkinson's disease","volume":"36","author":"Zurn","year":"2001","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.jconrel.2016.05.052_bb0060","article-title":"Pharmacodynamic and therapeutic investigation of focused ultrasound-induced blood-brain barrier opening for enhanced temozolomide delivery in glioma treatment","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2016.05.052_bb0065","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0928-0987(00)00209-8","article-title":"Development of gene drug delivery systems based on pharmacokinetic studies","volume":"13","author":"Takakura","year":"2001","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2016.05.052_bb0070","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1212\/WNL.60.1.69","article-title":"Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD","volume":"60","author":"Nutt","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jconrel.2016.05.052_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2014.06.023","article-title":"Magnetic-resonance imaging for kinetic analysis of permeability changes during focused ultrasound-induced blood-brain barrier opening and brain drug delivery","volume":"192","author":"Chai","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.05.052_bb0080","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12967-015-0451-y","article-title":"Focused ultrasound-induced blood-brain barrier opening to enhance interleukin-12 delivery for brain tumor immunotherapy: a preclinical feasibility study","volume":"13","author":"Chen","year":"2015","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jconrel.2016.05.052_bb0085","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neuroimage.2004.06.046","article-title":"Local and reversible blood\u2013brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications","volume":"24","author":"Hynynen","year":"2005","journal-title":"NeuroImage"},{"key":"10.1016\/j.jconrel.2016.05.052_bb0090","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1148\/radiol.2202001804","article-title":"Noninvasive MR imaging\u2013guided focal opening of the blood-brain barrier in rabbits","volume":"220","author":"Hynynen","year":"2001","journal-title":"Radiology"},{"key":"10.1016\/j.jconrel.2016.05.052_bb0095","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1148\/radiol.10090699","article-title":"Blood-brain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment","volume":"255","author":"Liu","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.jconrel.2016.05.052_bb0100","doi-asserted-by":"crossref","first-page":"15205","DOI":"10.1073\/pnas.1003388107","article-title":"Magnetic resonance monitoring of focused ultrasound\/magnetic nanoparticle targeting delivery of therapeutic agents to the brain","volume":"107","author":"Liu","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2016.05.052_bb0105","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3174\/ajnr.A3150","article-title":"Neuronavigation-guided focused ultrasound-induced blood-brain barrier opening: a preliminary study in swine","volume":"34","author":"Wei","year":"2013","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.jconrel.2016.05.052_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2015.06.010","article-title":"Focused ultrasound-induced blood-brain barrier opening for non-viral, non-invasive, and targeted gene delivery","volume":"212","author":"Lin","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.05.052_bb0115","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/mt.2011.11","article-title":"Interventional MRI-guided putaminal delivery of AAV2-GDNF for a planned clinical trial in Parkinson's disease","volume":"19","author":"Richardson","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2016.05.052_bb0120","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jconrel.2008.12.010","article-title":"Effective GDNF brain delivery using microspheres\u2014a promising strategy for Parkinson's disease","volume":"135","author":"Garbayo","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.05.052_bb0125","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jconrel.2010.07.115","article-title":"Ultrasound-triggered release of materials entrapped in microbubble-liposome constructs: a tool for targeted drug delivery","volume":"148","author":"Klibanov","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.05.052_bb0130","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jconrel.2012.12.025","article-title":"Paclitaxel-liposome-microbubble complexes as ultrasound-triggered therapeutic drug delivery carriers","volume":"166","author":"Yan","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.05.052_bb0135","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.nano.2013.06.011","article-title":"Ultrasound sensitive eLiposomes containing doxorubicin for drug targeting therapy","volume":"10","author":"Lin","year":"2014","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.jconrel.2016.05.052_bb0140","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nprot.2006.342","article-title":"Protocol for the MPTP mouse model of Parkinson's disease","volume":"2","author":"Jackson-Lewis","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jconrel.2016.05.052_bb0145","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.neulet.2016.01.048","article-title":"Neuroprotective effects of stemazole in the MPTP-induced acute model of Parkinson's disease: involvement of the dopamine system","volume":"616","author":"Guo","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jconrel.2016.05.052_bb0150","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1600-0404.1991.tb05017.x","article-title":"Subclinical damage to the nigrostriatal dopamine system by MPTP as a model of preclinical Parkinson's disease: a review","volume":"136","author":"Burns","year":"1991","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"10.1016\/j.jconrel.2016.05.052_bb0155","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jconrel.2016.05.052_bb0160","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1148\/radiol.14140245","article-title":"Alzheimer disease in a mouse model: MR imaging-guided focused ultrasound targeted to the hippocampus opens the blood-brain barrier and improves pathologic abnormalities and behavior","volume":"273","author":"Burgess","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.jconrel.2016.05.052_bb0165","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jconrel.2013.08.029","article-title":"Drug delivery to the brain by focused ultrasound induced blood-brain barrier disruption: quantitative evaluation of enhanced permeability of cerebral vasculature using two-photon microscopy","volume":"172","author":"Nhan","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.05.052_bb0170","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jconrel.2015.12.034","article-title":"Targeted gene transfer to the brain via the delivery of brain-penetrating DNA nanoparticles with focused ultrasound","volume":"223","author":"Mead","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.05.052_bb0175","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0301-5629(00)00200-3","article-title":"Ultrasound enhancement of liposome-mediated cell transfection is caused by cavitation effects","volume":"26","author":"Koch","year":"2000","journal-title":"Ultrasound Med. Biol."},{"key":"10.1016\/j.jconrel.2016.05.052_bb0180","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jconrel.2006.09.008","article-title":"Gene delivery by combination of novel liposomal bubbles with perfluoropropane and ultrasound","volume":"117","author":"Suzuki","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.05.052_bb0185","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.neurobiolaging.2005.01.009","article-title":"Molecular mechanism of the neurotrophic effect of GDNF on DA neurons: role of protein kinase CK2","volume":"27","author":"Chao","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jconrel.2016.05.052_bb0190","first-page":"10","article-title":"GDNF-based therapies, GDNF-producing interneurons, and trophic support of the dopaminergic nigrostriatal pathway. Implications for Parkinson's disease","volume":"9","author":"d'Anglemont de Tassigny","year":"2015","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.jconrel.2016.05.052_bb0195","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.brainresbull.2008.03.007","article-title":"The involvement of NF-kappaB p65\/p52 in the effects of GDNF on DA neurons in early PD rats","volume":"76","author":"Cao","year":"2008","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.jconrel.2016.05.052_bb0200","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1021\/mp800154s","article-title":"Ultrasound exposure of lipoplex loaded microbubbles facilitates direct cytoplasmic entry of the lipoplexes","volume":"6","author":"Lentacker","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2016.05.052_bb0205","doi-asserted-by":"crossref","first-page":"19579","DOI":"10.1038\/srep19579","article-title":"Noninvasive, targeted, and non-viral ultrasound-mediated GDNF-plasmid delivery for treatment of Parkinson's disease","volume":"6","author":"Fan","year":"2016","journal-title":"Sci. Rep."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365916303315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365916303315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T16:34:05Z","timestamp":1785774845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365916303315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":41,"alternative-id":["S0168365916303315"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2016.05.052","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-invasive, neuron-specific gene therapy by focused ultrasound-induced blood-brain barrier opening in Parkinson's disease mouse model","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2016.05.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}